AXM Pharma Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2017	FY 2005
Period Ending	Jun '18 Jun 30, 2018	Dec '17 Dec 31, 2017	Dec '05 Dec 31, 2005
Revenue	110.68	113.08	2.02
Revenue Growth (YoY)	-	5493.37%	-
Cost of Revenue	89.91	93	-
Gross Profit	20.77	20.08	0.77
Selling, General & Admin	8.13	5.3	-
Other Operating Expenses	0.18	0.68	-
Operating Expenses	8.31	5.98	-
Operating Income	12.46	14.11	-
Interest Expense	-	-0.73	-
Other Non Operating Income (Expenses)	-1.67	-1.16	-
Pretax Income	11.91	12.21	-
Income Tax Expense	3.56	4.03	-
Earnings From Continuing Operations	-	8.18	-
Net Income	8.35	8.18	-11.09
Net Income to Common	8.35	8.18	-
Shares Outstanding (Basic)	5,300	5,300	-
Shares Outstanding (Diluted)	5,300	5,300	-
EPS (Basic)	0.00	0.00	-
EPS (Diluted)	0.00	0.00	-
Free Cash Flow	-	13.14	-
Free Cash Flow Per Share	-	0.00	-
Gross Margin	18.77%	17.76%	38.20%
Operating Margin	11.26%	12.47%	-
Profit Margin	7.54%	7.23%	-
Free Cash Flow Margin	-	11.62%	-
EBITDA	-	15.27	-
EBITDA Margin	-	13.50%	-
D&A For EBITDA	-	1.16	-
EBIT	12.46	14.11	-
EBIT Margin	11.26%	12.47%	-
Effective Tax Rate	29.88%	33.00%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.